Showing 1 - 6 results of 6 for search 'Yongkun Wei', query time: 0.03s Refine Results
  1. 1
    Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment

    Editorial: Drug-induced immunogenic cell death patterns and anti-cancer treatment by Xianghou Xia, Zu Ye, Sajjad Ahmad, Yongkun Wei, Yang Yu

    Published 2023-07-01
    Get full text
    Article
  2. 2
    Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning

    Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning by Xinzhou Huang, Jinliang Ma, Yongkun Wei, Hui Chen, Wei Chu

    Published 2023-07-01
    Get full text
    Article
  3. 3
    An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response

    An optimized protocol for PD-L1 pathological assessment with patient sample deglycosylation to improve correlation with therapeutic response by Ying-Nai Wang, Heng-Huan Lee, Yongkun Wei, Yu-Yi Chu, Weiya Xia, Michael Wang, Dihua Yu, Mien-Chie Hung

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer

    Author Correction: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer by Lei Nie, Yongkun Wei, Fei Zhang, Yi-Hsin Hsu, Li-Chuan Chan, Weiya Xia, Baozhen Ke, Cihui Zhu, Rong Deng, Jun Tang, Jun Yao, Yu-Yi Chu, Xixi Zhao, Ye Han, Junwei Hou, Longfei Huo, How-Wen Ko, Wan-Chi Lin, Hirohito Yamaguchi, Jung-Mao Hsu, Yi Yang, Dean N. Pan, Jennifer L. Hsu, Celina G. Kleer, Nancy E. Davidson, Gabriel N. Hortobagyi, Mien-Chie Hung

    Published 2020-01-01
    Get full text
    Article
  5. 5
    Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

    Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation by Heng-Huan Lee, Ying-Nai Wang, Wen-Hao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan, Yu-Han Wang, Zhou Jiang, Shouping Xu, Jun Yao, Yufan Qiu, Yi-Hsin Hsu, Wei-Lun Hwang, Meisi Yan, Jong-Ho Cha, Jennifer L. Hsu, Jia Shen, Yuanqing Ye, Xifeng Wu, Ming-Feng Hou, Lin-Ming Tseng, Shao-Chun Wang, Mei-Ren Pan, Chin-Hua Yang, Yuan-Liang Wang, Hirohito Yamaguchi, Da Pang, Gabriel N. Hortobagyi, Dihua Yu, Mien-Chie Hung

    Published 2021-05-01
    Get full text
    Article
  6. 6
    ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer

    ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer by Peijing Zhang, Zhenna Xiao, Shouyu Wang, Mutian Zhang, Yongkun Wei, Qinglei Hang, Jongchan Kim, Fan Yao, Cristian Rodriguez-Aguayo, Baochau N. Ton, Minjung Lee, Yumeng Wang, Zhicheng Zhou, Liyong Zeng, Xiaoyu Hu, Sarah E. Lawhon, Ashley N. Siverly, Xiaohua Su, Jia Li, Xiaoping Xie, Xuhong Cheng, Liang-Chiu Liu, Hui-Wen Chang, Shu-Fen Chiang, Gabriel Lopez-Berestein, Anil K. Sood, Junjie Chen, M. James You, Shao-Cong Sun, Han Liang, Yun Huang, Xianbin Yang, Deqiang Sun, Yutong Sun, Mien-Chie Hung, Li Ma

    Published 2018-04-01
    Get full text
    Article

Search Tools: